THREE-YEAR RESULTS FROM THE EVOLVE II RANDOMIZED TRIAL: LATE CLINICAL OUTCOMES WITH BIORESORBABLE COMPARED TO PERMANENT POLYMER EVEROLIMUS-ELUTING

被引：1
|
作者：
Kereiakes, Dean J. [1 ]
Meredith, Ian [1 ]
Windecker, Stephan [1 ]
Rodes-Cabau, Josep [1 ]
Lee, Tommy [1 ]
Reitman, Arthur [1 ]
Erglis, Andrejs [1 ]
Dorogy, Mark [1 ]
Bertolet, Barry [1 ]
Cannon, Louis [1 ]
Airaksinen, Juhani [1 ]
Siegel, Craig [1 ]
Christen, Thomas [1 ]
Allocco, Dominic [1 ]
Dawkins, Keith [1 ]
机构：
[1] Christ Hosp, Heart & Vasc Ctr, Lindner Res Ctr, Cincinnati, OH 45219 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2017年 / 69卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(17)34359-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1135M-09
引用
收藏
页码：970 / 970
页数：1
相关论文
共 50 条
  • [31] Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial
    Arroyo, Diego
    Togni, Mario
    Puricel, Serban
    Gerard, Baeriswyl
    Sonja, Lehmann
    Corpataux, Noe
    Villeneuve, Helene
    Boute, Estelle
    Stauffer, Jean-Christophe
    Goy, Jean-Jacques
    Cook, Stephane
    TRIALS, 2014, 15
  • [32] Primary Clinical and Angiographic Outcomes of the EVOLVE Trial: A Randomized Evaluation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent
    Meredith, Ian T.
    Verheye, Stefan
    Dubois, Christophe L.
    Dens, Joseph
    Fajadet, Jean
    Carrie, Didier
    Walsh, Simon
    Oldroyd, Keith G.
    Varenne, Olivier
    El-Jack, Seif
    Moreno, Raul
    Joshi, Anita A.
    Allocco, Dominic J.
    Dawkins, Keith D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : XIV - XIV
  • [33] Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial
    Lansky, Alexandra J.
    Yaqub, Manejeh
    Hermiller, James B.
    Smith, Robert S., Jr.
    Farhat, Naim
    Caputo, Ronald
    Williams, Jerome E.
    Sanz, Mark
    Koo, Kai
    Sood, Poornima
    Sudhir, Krishnankutty
    Stone, Gregg W.
    EUROINTERVENTION, 2010, 6 : J44 - J52
  • [34] Efficacy and Safety of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent The EVOLVE II Randomized Trial
    Kereiakes, Dean J.
    Meredith, Ian T.
    Windecker, Stephan
    Jobe, R. Lee
    Mehta, Shamir R.
    Sarembock, Ian J.
    Feldman, Robert L.
    Stein, Bernardo
    Dubois, Christophe
    Grady, Timothy
    Saito, Shigeru
    Kimura, Takeshi
    Christen, Thomas
    Allocco, Dominic J.
    Dawkins, Keith D.
    Circulation-Cardiovascular Interventions, 2015, 8 (04)
  • [35] Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
    Meredith, Ian T.
    Verheye, Stefan
    Dubois, Christophe
    Dens, Joseph
    Farah, Bruno
    Carrie, Didier
    Walsh, Simon
    Oldroyd, Keith
    Varenne, Olivier
    El-Jack, Seif
    Moreno, Raul
    Christen, Thomas
    Allocco, Dominic J.
    EUROINTERVENTION, 2018, 13 (17) : 2047 - 2050
  • [36] Bioresorbable polymer sirolimus-eluting coronary stent compared with permanent polymer everolimus-eluting coronary stent implantation for treatment of small vessel coronary artery disease: CENTURY II trial
    Woehrle, Jochen
    Markovic, Sinisa
    Rottbauer, Wolfgang
    Muramatsu, Toshiya
    Kadota, Kazushige
    Vazquez-Gonzalez, Nicolas
    Odenstedt, Jacob
    Serra, Antonio
    Antoniucci, David
    Varenne, Olivier
    Saito, Shigeru
    Wijns, William
    EUROINTERVENTION, 2016, 12 (02) : E167 - E174
  • [37] The long-term impact of post-procedural asymmetry and eccentricity of bioresorbable everolimus-eluting scaffold and metallic everolimus-eluting stent on clinical outcomes in the ABSORB II trial
    Katagiri, Y.
    Serruys, P. W. S.
    Macaya, C. M.
    Ormiston, J. O.
    Hill, J. H.
    Lang, I. M. L.
    Egred, M. E.
    Fajadet, J. F.
    Lesiak, M. L.
    Wykrzykowska, J. J. W.
    Piek, J. J. P.
    Sabate, M. S.
    Windecker, S. W.
    Chevalier, B. C.
    EUROPEAN HEART JOURNAL, 2018, 39 : 545 - 545
  • [38] Long-Term (Three-Year) Safety and Efficacy of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents (from the SPIRIT III Trial)
    Applegate, Robert J.
    Yaqub, Manejeh
    Hermiller, James B.
    Sood, Poornima
    Yu, Shui
    Doostzadeh, Julie
    Williams, Jerome E.
    Farhat, Naim
    Caputo, Ronald
    Lansky, Alexandra J.
    Cutlip, Donald E.
    Sudhir, Krishnankutty
    Stone, Gregg W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (06): : 833 - 840
  • [39] The Long-Term Impact of Post-Procedural Asymmetry and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial
    Katagiri, Yuki
    Serruys, Patrick W.
    Macaya, Carlos
    Ormiston, John A.
    Hill, Jonathan
    Lang, Irene M.
    Egred, Mohaned
    Fajadet, Jean
    Lesiak, Maciej
    Wykrzykowska, Joanna J.
    Piek, Jan J.
    Sabate, Manel
    Windecker, Stephan
    Chevalier, Bernard
    Onuma, Yoshinobu
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (10) : 1013 - 1015
  • [40] Five-year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds
    Schukraft, Sara
    Arroyo, Diego
    Togni, Mario
    Goy, Jean-Jacques
    Wenaweser, Peter
    Stadelmann, Mathieu
    Baeriswyl, Gerard
    Muller, Olivier
    Stauffer, Jean-Christophe
    Puricel, Serban
    Cook, Stephane
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2022, 99 (03) : 523 - 532
12345